Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-02-25 @ 8:15 PM
Study NCT ID:
NCT03911557
Status:
COMPLETED
Last Update Posted:
2025-11-12
First Post:
2019-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
Sponsor:
John L. Villano, MD, PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-10
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-09
First Submit QC Date:
None
Study First Post Date:
2019-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-10
Last Update Post Date:
2025-11-12
Last Update Post Date Type:
ESTIMATED